XML 102 R6.htm IDEA: XBRL DOCUMENT v3.25.4
Condensed Consolidated Statements of Comprehensive Income - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]            
Net loss $ (7,618,776) $ (1,999,694) $ (17,874,085) $ (6,758,630) $ (8,707,226) $ (9,212,417)
Other comprehensive income (loss)            
Foreign currency translation adjustments (45) (497) (2,079) (1,663) (9,845)
Comprehensive loss (7,618,821) (2,000,191) (17,876,164) (6,760,293) (8,717,071) (9,212,417)
Other comprehensive expense            
Less comprehensive loss attributed to non-controlling interest (558) (461) (658) (837) (1,081)
Comprehensive loss attributable to Mangoceuticals, Inc. stockholders $ (7,618,263) $ (1,999,730) $ (17,875,506) $ (6,759,456) $ (8,715,990) $ (9,212,417)